Public engagement and clinical trials: new models and disruptive technologies : workshop summary
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Washington, D.C.
National Academies Press
2011
|
Schlagworte: | |
Beschreibung: | Includes bibliographical references |
Beschreibung: | xvi, 99 p. |
ISBN: | 9780309219297 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV044109323 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 170217s2011 |||| o||u| ||||||eng d | ||
020 | |a 9780309219297 |c Online |9 978-0-309-21929-7 | ||
035 | |a (ZDB-30-PAD)EBC3378890 | ||
035 | |a (ZDB-89-EBL)EBL3378890 | ||
035 | |a (OCoLC)769188485 | ||
035 | |a (OCoLC)923284553 | ||
035 | |a (DE-599)BVBBV044109323 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
082 | 0 | |a 610.724 |2 23 | |
245 | 1 | 0 | |a Public engagement and clinical trials |b new models and disruptive technologies : workshop summary |c Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies |
264 | 1 | |a Washington, D.C. |b National Academies Press |c 2011 | |
300 | |a xvi, 99 p. | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references | ||
650 | 4 | |a Clinical trials | |
700 | 1 | |a Weisfeld, Victoria |e Sonstige |4 oth | |
700 | 1 | |a English, Rebecca A. |e Sonstige |4 oth | |
700 | 1 | |a Claiborne, Anne B. |e Sonstige |4 oth | |
710 | 2 | |a Institute of Medicine (U.S.) |e Sonstige |4 oth | |
912 | |a ZDB-30-PAD | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029516168 |
Datensatz im Suchindex
_version_ | 1804177182700863488 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV044109323 |
collection | ZDB-30-PAD |
ctrlnum | (ZDB-30-PAD)EBC3378890 (ZDB-89-EBL)EBL3378890 (OCoLC)769188485 (OCoLC)923284553 (DE-599)BVBBV044109323 |
dewey-full | 610.724 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 610 - Medicine and health |
dewey-raw | 610.724 |
dewey-search | 610.724 |
dewey-sort | 3610.724 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01384nmm a2200361zc 4500</leader><controlfield tag="001">BV044109323</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309219297</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-309-21929-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3378890</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3378890</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)769188485</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)923284553</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044109323</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610.724</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Public engagement and clinical trials</subfield><subfield code="b">new models and disruptive technologies : workshop summary</subfield><subfield code="c">Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xvi, 99 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weisfeld, Victoria</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">English, Rebecca A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claiborne, Anne B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029516168</subfield></datafield></record></collection> |
id | DE-604.BV044109323 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:43:55Z |
institution | BVB |
isbn | 9780309219297 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029516168 |
oclc_num | 769188485 923284553 |
open_access_boolean | |
physical | xvi, 99 p. |
psigel | ZDB-30-PAD |
publishDate | 2011 |
publishDateSearch | 2011 |
publishDateSort | 2011 |
publisher | National Academies Press |
record_format | marc |
spelling | Public engagement and clinical trials new models and disruptive technologies : workshop summary Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies Washington, D.C. National Academies Press 2011 xvi, 99 p. txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references Clinical trials Weisfeld, Victoria Sonstige oth English, Rebecca A. Sonstige oth Claiborne, Anne B. Sonstige oth Institute of Medicine (U.S.) Sonstige oth |
spellingShingle | Public engagement and clinical trials new models and disruptive technologies : workshop summary Clinical trials |
title | Public engagement and clinical trials new models and disruptive technologies : workshop summary |
title_auth | Public engagement and clinical trials new models and disruptive technologies : workshop summary |
title_exact_search | Public engagement and clinical trials new models and disruptive technologies : workshop summary |
title_full | Public engagement and clinical trials new models and disruptive technologies : workshop summary Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies |
title_fullStr | Public engagement and clinical trials new models and disruptive technologies : workshop summary Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies |
title_full_unstemmed | Public engagement and clinical trials new models and disruptive technologies : workshop summary Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies |
title_short | Public engagement and clinical trials |
title_sort | public engagement and clinical trials new models and disruptive technologies workshop summary |
title_sub | new models and disruptive technologies : workshop summary |
topic | Clinical trials |
topic_facet | Clinical trials |
work_keys_str_mv | AT weisfeldvictoria publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT englishrebeccaa publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT claiborneanneb publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT instituteofmedicineus publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary |